BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugase T, Takahashi T, Ishikawa T, Ichikawa H, Kanda T, Hirota S, Nakajima K, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Takiguchi S, Wakai T, Mori M, Doki Y. Surgical resection of recurrent gastrointestinal stromal tumor after interruption of long-term nilotinib therapy. Surg Case Rep 2016;2:137. [PMID: 27864817 DOI: 10.1186/s40792-016-0266-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Hamid AB, Petreaca RC. Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells. Cancers (Basel) 2020;12:E927. [PMID: 32283832 DOI: 10.3390/cancers12040927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Li Y, An ZJ, Tan BB, Zhao Q, Fan LQ, Zhao XF. Research status and progress of drug resistance in gastrointestinal stromal tumors. Shijie Huaren Xiaohua Zazhi 2020; 28(20): 999-1003 [DOI: 10.11569/wcjd.v28.i20.999] [Reference Citation Analysis]
3 Apsel Winger B, Cortopassi WA, Garrido Ruiz D, Ding L, Jang K, Leyte-Vidal A, Zhang N, Esteve-Puig R, Jacobson MP, Shah NP. ATP-Competitive Inhibitors Midostaurin and Avapritinib Have Distinct Resistance Profiles in Exon 17-Mutant KIT. Cancer Res 2019;79:4283-92. [PMID: 31270078 DOI: 10.1158/0008-5472.CAN-18-3139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wang J, Wu J, Hong C, Wang Y, Zhou Y, Long Z, Zhou Y, Qin H. Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16 Ink4A /p14 ARF gene expressions: An in vivo and in vitro study. Pathology - Research and Practice 2017;213:1542-51. [DOI: 10.1016/j.prp.2017.09.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]